Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Other Non-Current Liabilities (2020 - 2025)

RxSight (RXST) has disclosed Other Non-Current Liabilities for 4 consecutive years, with $1.7 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Other Non-Current Liabilities rose 2197.3% year-over-year to $1.7 million, compared with a TTM value of $1.7 million through Dec 2024, up 2197.3%, and an annual FY2024 reading of $1.7 million, up 2197.3% over the prior year.
  • Other Non-Current Liabilities was $1.7 million for Q4 2024 at RxSight, up from $74000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $5.0 million in Q4 2020 and bottomed at $74000.0 in Q4 2023.
  • Average Other Non-Current Liabilities over 4 years is $1.6 million, with a median of $888000.0 recorded in 2023.
  • Peak annual rise in Other Non-Current Liabilities hit 2197.3% in 2024, while the deepest fall reached 2197.3% in 2024.
  • Year by year, Other Non-Current Liabilities stood at $5.0 million in 2020, then crashed by 47.91% to $2.6 million in 2021, then crashed by 97.17% to $74000.0 in 2023, then surged by 2197.3% to $1.7 million in 2024.
  • Business Quant data shows Other Non-Current Liabilities for RXST at $1.7 million in Q4 2024, $74000.0 in Q4 2023, and $75000.0 in Q3 2023.